SCHEMBL173752

SCHEMBL173752

CC=CC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBLB Q13191 5/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
APEX1 P27695 1/20 0.39
EPHX2 P34913 1/20 0.38
HDAC1 Q13547 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
ZDHHC20 Q5W0Z9 1/20 0.32
ZDHHC2 Q9UIJ5 1/20 0.32
MAPT P10636 1/20 0.32
EGFR P00533 1/20 0.31
BRD4 O60885 2/20 0.31
ALDH1A1 P00352 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
HTR1A P08908 2/20 0.30
HTR2C P28335 2/20 0.30
HTR2A P28223 1/20 0.30
SLC6A4 P31645 1/20 0.30
HTR7 P34969 1/20 0.30
HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL721100 0.99 CBLB (0.39) CBLBKMT2AATMAPEX1EPHX2
Hydrochloric Acid SCHEMBL3644712 0.99 CBLB (0.39) CBLBKMT2AATMAPEX1EPHX2
SCHEMBL3288796 0.86 APEX1 (0.44) KMT2AAPEX1EPHX2HDAC1SMN1; SMN2
Water SCHEMBL28011897 0.85 EPHX2 (0.41) CBLBKMT2AATMEPHX2HDAC1
SCHEMBL3890436 0.84 ZDHHC20 (0.50) CBLBKMT2AATMEPHX2ZDHHC20
SCHEMBL19547975 0.83 BBOX1 (0.41) CBLBKMT2AATMAPEX1EPHX2
Water SCHEMBL15389892 0.82 ZDHHC20 (0.49) CBLBKMT2AATMEPHX2ZDHHC20
Sulfuric Acid SCHEMBL25230184 0.81 APEX1 (0.42) CBLBKMT2AATMAPEX1SMN1; SMN2
Water SCHEMBL19888881 0.80 CBLB (0.36) CBLBKMT2AATMAPEX1
SCHEMBL12210469 0.80 KDM4E (0.50) CBLBKMT2AATMEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11752250-B2 Hemocompatibility modifiers for cross-linked polymeric material CYTOSORBENTS CORPORATION (US) 2023-09-12 US disclosed
EP-3990431-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT Johnson & Johnson Vision Care, Inc. (US) 2022-05-04 EP disclosed
WO-2020261021-A1 POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT JOHNSON & JOHNSON VISION CARE, INC. (US) 2020-12-30 WO disclosed
EP-2801401-B1 OUTSTANDINGLY CONTAMINATION RESISTANT REVERSE OSMOSIS MEMBRANE AND PRODUCTION METHOD THEREFOR LG CHEMICAL LTD (KR) 2018-12-12 EP disclosed
EP-3274503-A1 DURABLY ASSOCIATED SOIL ADSORBING COMPOSITES, COMPOSITIONS, AND METHODS FOR USING SAME The Procter and Gamble Company (US) 2018-01-31 EP disclosed
EP-3274504-A1 SOIL ADSORBING COMPOSITES, COMPOSITIONS, AND METHODS FOR USING SAME The Procter and Gamble Company (US) 2018-01-31 EP disclosed
WO-2016160503-A1 DURABLY ASSOCIATED SOIL ADSORBING COMPOSITES, COMPOSITIONS, AND METHODS FOR USING SAME THE PROCTER & GAMBLE COMPANY (US) 2016-10-06 WO disclosed
EP-3010387-A1 LAMINATE CLEANING IMPLEMENT The Procter & Gamble Company (US) 2016-04-27 EP disclosed
EP-3010388-A1 BONDED LAMINATE CLEANING IMPLEMENT The Procter & Gamble Company (US) 2016-04-27 EP disclosed
EP-1831305-B1 GRAFT COPOLYMERS WITH SEGMENTED ARMS COATINGS FOREIGN IP CO LLC (US) 2015-08-12 EP disclosed
US-20110207216-A1 Synthetic Peptide (Meth) Acrylate Microcarriers CORNING INCORPORATED 2011-08-25 US disclosed
WO-2011017050-A1 SYNTHETIC MICROCARRIERS FOR CULTURING CELLS CORNING INCORPORATED (US) 2011-02-10 WO disclosed
US-20110027889-A1 Synthetic Microcarriers for Culturing Cells CORNING INCORPORATED 2011-02-03 US disclosed
US-20110027888-A1 Coated Fibers for Culturing Cells CORNING INCORPORATED 2011-02-03 US disclosed
US-20100248366-A1 Synthetic Surfaces for Differentiating Stem Cells into Cardiomyocytes GERON CORPORATION 2010-09-30 US disclosed
US-20090191627-A1 SYNTHETIC SURFACES FOR CULTURING CELLS IN CHEMICALLY DEFINED MEDIA GERON CORPORATION 2009-07-30 US disclosed
US-7402624-B2 Graft copolymers with segmented arms and their preparation and use E.I. DU PONT DE NEMOURS & COMPANY (US) 2008-07-22 US disclosed
EP-1831305-A2 GRAFT COPOLYMERS WITH SEGMENTED ARMS AND THEIR PREPARATION AND USE E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-09-12 EP disclosed
WO-2006052981-A2 GRAFT COPOLYMERS WITH SEGMENTED ARMS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-05-18 WO disclosed
US-20060100305-A1 Graft copolymers with segmented arms and their preparation and use AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11752250-B2 Hemocompatibility modifiers for cross-linked polymeric material SELE, SELP, CD44 CBLB 802/4885KMT2A 2572/4885ATM 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.